CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Shares withheld for taxes Chief Legal Officer gave up 2,461 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 14,010 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 8,251 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 27,525 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 8,613 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,890 shares (to pay taxes)
- 4 Shares withheld for taxes Chief R&D Officer gave up 7,150 shares (to pay taxes)
- 4 Planned sale Director sold 7,000 shares at $7.54 ($52,780)
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 750 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Director acquired 647 shares (grant or award)
Page 9 of 99 · 1,967 filings